Genetic Differences Between Obesity and Waist-Hip Ratio
Author: DeCODE Genetics Inc
Published: 11 Oct 2010 - Updated: 20 Aug 2026
Publication Details: Peer-Reviewed | Findings
Table of Contents:
Synopsis - Definition - Overview - FAQs - Insights, Updates - Related Content
Synopsis
This article provides valuable insights into the relationship between obesity and waist-hip ratio (WHR), highlighting the genetic differences that influence fat distribution and obesity. It explains how WHR serves as a crucial indicator for health risks like diabetes and heart disease, independent of body mass index (BMI). This information is particularly relevant for individuals with disabilities, seniors, or those managing weight-related health issues, offering a deeper understanding of how genetics impact health outcomes. The distinction between BMI and WHR can lead to more tailored health interventions.*
At a Glance
- 1 - The genetic findings were published in Nature Genetics.
- 2 - Researchers identified 18 new genome regions for obesity and 13 for waist-hip ratio.
- 3 - BMI-linked genes mainly affect appetite and satiety, while WHR genes shape how and where fat is stored.
- 4 - The meta-studies pooled genetic and body data from more than a quarter of a million participants across Europe, North America, and Australia.
Topic Definition
- Waist-Hip Ratio Genetics
Waist-hip ratio genetics is the study of the inherited factors that determine how the body distributes fat between the waist and the hips, rather than how much fat a person carries overall. Research in this area has shown that the genes influencing waist-hip ratio are largely separate from those tied to general obesity, with obesity-related genes acting mainly on appetite and satiety in the brain while waist-hip ratio genes govern the development and placement of fat tissue itself. One of the more striking observations is that many of these fat distribution genes have a noticeably stronger effect in women than in men, pointing to real biological differences in how the sexes store fat. Because waist-hip ratio is linked to the risk of diabetes, heart disease, and mortality independently of body mass index, understanding its genetic basis helps explain why two people of similar weight can face very different health outcomes.
Overview
Independent of Obesity Itself, WHR is a Key Indicator of Risk of Diabetes, Heart Disease and Mortality, and Appears to be Regulated Differently in Women and Men.
In two of the largest meta-studies of their kind to date, scientists from the GIANT consortium, including deCODE as well as hundreds of academic institutions on three continents, report the discovery of eighteen new regions of the human genome contributing to obesity and thirteen new regions influencing waist-hip ratio (WHR). The studies bring together data on body mass index (BMI, a measure of obesity), WHR (a measure of body fat distribution), and detailed genotypic information, from more than a quarter of a million participants from Europe, North America and Australia.
These findings demonstrate the effectiveness of collaborations such as GIANT for powering studies large enough to detect lower-impact genetic factors for common traits and diseases.
"To my mind, perhaps the most noteworthy aspect of these findings is that it has indeed been possible to find so many loci for WHR that are independent of BMI. Most of the BMI loci appear to affect central and neuronal processes regulating satiety and appetite. By contrast, the WHR loci appear to be involved in the development and distribution of adipose tissue. Thus, the genetics seems to be pointing us to biological distinctions between two components of the regulation of weight - how much we eat, and how and where calories are stored as fat."
"Also intriguing, many of the WHR loci show a significantly greater impact in women than in men, a distinction that is stronger here than in any other disease or trait we have looked at. From a health perspective, the distinctions drawn here between BMI and WHR are steps towards better understanding the role of these two traits as risk factors for a range of diseases," said Kari Stefansson, deCODE CEO and a senior author on the BMI study.
The papers, "Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index," and "Meta-analysis identifies 13 novel loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution," are published online in Nature Genetics.
About deCODE
Headquartered in Reykjavik, Iceland, deCODE genetics is a global leader in analyzing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
deCODE employs its capabilities to develop DNA-based tests and personal genome scans to better understand individual risk and empower prevention. It licenses its tests, intellectual property and analytical tools to partners, and conducts genotyping, sequencing and data analysis for companies and research institutions around the globe. Through its CLIA- and CAP-certified laboratory deCODE offers DNA-based tests for gaging risk and empowering prevention of common diseases, including deCODE Glaucoma; deCODE T2 for type 2 diabetes; deCODE AF for atrial fibrillation and stroke; deCODE MI for heart attack; deCODE Prostate Cancer; and deCODE BreastCancer, for the common forms of breast cancer.
Through its pioneering personal genome analysis service deCODEme, deCODE enables individuals to better understand their risk of dozens of common diseases and to learn about their ancestry and other traits.
Frequently Asked Questions
NOTE: Researched FAQs by Disabled World (DW)
What is the GIANT consortium?
The GIANT consortium is a large international research collaboration that combines genetic and physical data from many institutions to study the inherited factors behind traits such as body size and fat distribution.
How is waist-hip ratio different from body mass index?
Waist-hip ratio compares the waist measurement to the hip measurement to describe where fat sits, while body mass index uses height and weight to estimate overall body fat regardless of its location.
Why does it matter that some genes affect fat distribution more in women than in men?
It suggests that the biology of fat storage is partly shaped by sex, which may help explain differences in disease risk between women and men and support more tailored health guidance.
Can knowing my genetic risk change how I manage my weight?
Genetic insight can inform prevention and lifestyle choices, but weight management still relies on diet, activity, and medical guidance rather than genetics alone.
Are these genetic findings relevant to people with disabilities and seniors?
Yes, because they support using waist-hip ratio alongside body mass index, which can give a clearer health picture for those whose body composition shifts with age or limited mobility.
What does it mean that a gene region is associated with a trait?
It means variation in that part of the genome is statistically linked to differences in the trait across many people, though a single region usually has only a small individual effect.
Does having these gene variants guarantee a person will become obese?
No, these variants raise or lower likelihood rather than determine an outcome, and environment, diet, and activity play major roles alongside genetics.
Why do researchers study such large numbers of participants?
Large samples give studies the statistical power to detect genetic factors that have small individual effects, which would remain hidden in smaller groups.
Insights, Analysis, and Developments
Editorial Note: The insights offered in this article challenge conventional reliance on BMI as a universal standard for obesity assessment. By advocating for waist-to-hip ratio as a more precise indicator, it opens the door to improved health evaluations for seniors and disabled individuals, ensuring that age-related changes in body composition are accounted for. This shift in focus could lead to better-targeted interventions and healthier outcomes for vulnerable populations.*
Attribution/Source(s): This peer reviewed publication was selected for publishing by the editors of Disabled World (DW) due to its relevance to the disability community. Originally authored by DeCODE Genetics Inc and published on 11 Oct 2010, this content may have been edited for style, clarity, or brevity.
* Editorial additions by Ian C. Langtree.